Jazz Pharmaceuticals (JAZZ) Financial Analysis & Valuation | Quarter Chart
Jazz Pharmaceuticals (JAZZ)
JAZZPrice: $237.72
Fair Value: 🔒
🔒score
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuro... more
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes phar... more
Description
Shares
| Market Cap | $14.93B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | IE | CEO | Renee D. Gala |
| IPO Date | 2007-06-01 | CAGR | — |
| Employees | 2,890 | Website | www.jazzpharma.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.84% | Total Yield | 0.84% |
JAZZ chart loading...
Fundamentals
Technicals
| Enterprise Value | $15.22B | P/E Ratio | 18.49 |
| Forward P/E | 9.28 | PEG Ratio | — |
| P/S Ratio | 3.3 | P/B Ratio | 3.18 |
| P/CF Ratio | 10.85 | P/FCF Ratio | 11.77 |
| EPS | $12.86 | EPS Growth 1Y | -98.53% |
| EPS Growth 3Y | — | EPS Growth 5Y | -98.79% |
| Revenue Growth 1Y | 9.2% | Gross Margin | 0.84% |
| Operating Margin | 0.11% | Profit Margin | 0.01% |
| ROE | 0.01% | ROA | — |
| ROCE | 0.05% | Current Ratio | 2.04 |
| Quick Ratio | 1.85 | Cash Ratio | 0.82 |
| Debt/Equity | 1.2 | Interest Coverage | 2.41 |
| Altman Z Score | 1.9 | Piotroski Score | 6 |